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SLC35A3) are evolutionarily related. We hypothesize that their role in glycosylation may be coupled
through heterologous complex formation. Coimmunoprecipitation analysis and FLIM–FRET mea-
surements performed on living cells showed that NGT and UGT form complexes when overexpressed
in MDCK-RCAr cells. We also postulate that the interaction of NGT and UGT may explain the dual
localization of UGT2. For the ﬁrst time we demonstrated in vivo homodimerization of the NGT nucle-
otide sugar transporter. In conclusion, we suggest that NGT and UGT function in glycosylation is
combined via their mutual interaction.
Structured summary of protein interactions:
NGT physically interacts with UGT2 by anti tag coimmunoprecipitation (View Interaction: 1, 2)
NGT physically interacts with UGT1 by anti tag coimmunoprecipitation (View interaction)
UGT2 physically interacts with NGT by ﬂuorescent resonance energy transfer (View interaction)
NGT physically interacts with NGT by ﬂuorescent resonance energy transfer (View interaction)
UGT1 physically interacts with UGT2 by anti tag coimmunoprecipitation (View interaction)
UGT1 physically interacts with NGT by ﬂuorescent resonance energy transfer (View interaction)
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Cellular glycoconjugates play a variety of fundamental roles in
the growth and development of eukaryotes, as well as in the
host–pathogen interactions. The glycan moiety is synthesized
and modiﬁed by glycosyltransferases acting in the lumen of the
endoplasmic reticulum (ER) and Golgi apparatus. The substrates
required by glycosyltransferases are sugars activated by the addi-
tion of a nucleoside mono- or diphosphate (UDP, GDP, or CMP).
They are transported into the ER or Golgi apparatus by nucleotide
sugar transporters (NSTs), which are hydrophobic proteins with a
molecular weight of 30–45 kDa [1,2]. Most predictions determine
in these multitransmembrane proteins an even number of spans,
which results in the N and C termini facing the cytosol.
One of the best characterized NSTs is the UDP-galactose trans-
porter (UGT; SLC35A2). Detailed characterization of UGT was pos-
sible after mutant cell lines, such as MDCK-RCAr [3,4], CHO-Lec8
[5,6], and Had-1 [7], had been generated. Non-sense mutationschemical Societies. Published by E
hnology, University of Wro-
71 3752608.
pl (M. Olczak).identiﬁed in the mutant cells cause inhibition of UGT production,
resulting in glycoconjugates signiﬁcantly defective in galactosyla-
tion and sialylation [3,8]. Two splice variants of UDP-Gal trans-
porter (UGT1 and UGT2) have been identiﬁed in human tissues,
the CHO and MDCK cell lines [9–11].
Compared with mammalian UGT, knowledge regarding mam-
malian UDP-N-acetylglucosamine transporter (NGT) is limited.
Among known UDP-GlcNAc transporters, SLC35A3 is assumed to
play a main role in glycosylation [12,13], while the function of
SLC35D2 [14] and SLC35B4 [15] multispeciﬁc transporters appears
to be less important. Compared with SLC35A3, which is ubiqui-
tously expressed, SLC35D2 and SLC35B4 are less common and tis-
sue-speciﬁc. Immunoﬂuorescent microscopic analysis of NGT
(SLC35A3) overexpressed in CHO [13] and MDCK-RCAr [16] cells
demonstrated its localization in the Golgi apparatus.
NGT and UGT, two nucleotide sugar transporters involved in
essential glycosylation processes, are evolutionarily related [2,17–
19]. In addition, overexpression of NGT in UGT-defective cells partly
restores galactosylation [17]. Therefore, we suspected that their
role in glycosylation of macromolecules may be coupled and both
transporters may partially replace function played by its partner.
In an attempt to gain an insight into this hypothesis, we analyzedlsevier B.V. All rights reserved.
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Golgi membrane.
2. Materials and methods
2.1. Construction of expression plasmids, cell maintenance and
transfection
MDCK-RCAr mutant cells were grown and transfected with
expression plasmid(s) (Supplementary Table 1) as described previ-
ously [17,20]. Stable transfectants expressing NGT and UGT1/UGT2
combinations were selected in complete media containing 600 lg/
ml G-418 sulfate (InvivoGen, Toulouse, France). For the control
pull-down experiment, MDCK-RCAr mutant cells and MDCK-RCAr
cells stably expressing either B4-FLAG (human UDP-xylose/N-ace-
tylglucosamine transporter; SLC35B4) or UGT2-FLAG were
transiently transfected with HA-HsNGT expression plasmid (Sup-
plementary Table 1) and analyzed 4 days after transfection.
2.2. Cell lysis, coimmunoprecipitation and Western blotting
Cells (1  109) were washed in PBS and lysed using lysis buffer
(50 mM Tris–HCl; pH 8.0 with 1% NP-40) supplemented with pro-
tease inhibitor cocktail and 1 mM EDTA. Lysates were centrifuged
at 14000g for 15 min. Supernatants were pre-incubated over-
night at 4 C with anti-HA rabbit polyclonal antibody (1.5 lg;
Abcam, Cambridge, UK) and then incubated with Protein A-Sephar-
ose 4B (25 ll; Invitrogen, Camarillo, CA, USA) for 4 h at 4 C.
Samples were centrifuged at 2000g for 5 min, pellets washed ﬁve
times with lysis buffer, suspended in sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS–PAGE) sample buffer, and
incubated for 30 min at 65 C. Proteins were separated in 10%
SDS–PAGE gels and transferred onto nitrocellulose membranes
(Whatman, Dassel, Germany). After blocking, incubation with
anti-c-myc (0.1 lg/ml; Abcam) or anti-FLAG (1 ng/ml; Sigma–
Aldrich) antibody, and subsequently with horseradish peroxi-
dase-coupled goat anti-chicken IgY (0.2 lg/ml; Abcam) or
anti-mouse IgG (1:10000; Promega, Madison, WI, USA) antibody
was carried out. Immunoreactive proteins were visualized with
an enhanced chemiluminescence system (PerkinElmer, Whaltam,
MA, USA). Proteins subjected to coimmunoprecipitation were also
separated by SDS–PAGE and stained with colloidal Coomassie
Brilliant Blue (PAGEBLUE Protein Staining Solution; Fermentas,
Vilnius, Lituania).
2.3. Confocal and ﬂuorescence lifetime imaging microscopies of living
cells
MDCK-RCAr mutant cells were transiently transfected with
expression construct(s). After 48 h cells were seeded onto the 40-
mm cover glasses (Thermo Scientiﬁc, Rockford, IL, USA) placed in
60-mm culture dishes and allowed to grow for additional 24 h.
The standard growth medium was replaced with the phenol-free
minimal essential medium (Life Technologies, Paisley, UK) 16 h
prior to imaging. Confocal microscopy images were acquired using
the Zeiss LSM 510 META laser scanning confocal microscope (Zeiss,
Jena, Germany). ImageJ software was used to analyze and process
images (http://rsb.info.nih.gov/ij/). Time-resolved ﬂuorescence
imaging was performed with an LSM 510 microscope (Zeiss)
equipped with a TCSPC FLIM module (PicoQuant, Berlin, Germany).
The dishes with cells expressing fusion protein(s) were mounted in
a dedicated observation stage chamber (PeCon GmbH, Erbach,
Germany) and left for gas (5% CO2) and temperature (37 C) equil-
ibration. Fluorescence of eGFP was excited at 470 nmwith a pulsed
laser (40 MHz) and collected through water immersion 63  LCIPlan-Neoﬂuar (NA 1.3) objective (Zeiss). The bandpass
500 ± 20 nm emission ﬁlter (Semrock, Lake Forest, IL, USA) was
used and suitable controls to exclude the excitation cross-talk arti-
facts were performed. Laser power was adjusted to give an average
photon rate of 104–105 photons to avoid the pile-up effect and sig-
niﬁcant photobleaching. About 500 photons per pixel were ac-
quired and the photon statistics were further improved by 2  2
pixel binning. A robust ﬁtting-free fast-FLIM approach was used
to reconstruct FLIM images in which every pixel was colored
according to the photon’s average arrival time.
2.4. Analysis of FLIM–FRET experiments
Two ﬂorescence decay models for FLIM–FRET data analysis
were applied. Validity of decay model was determined by weighted
residuals, which for a good ﬁt ﬂuctuate randomly around zero with
no obvious trends and by v2 value, which is close to 1 for a good ﬁt.
First, FLIM–FRET data were tail-ﬁtted to single exponential decay.
Such model described properly decays obtained from control cells,
however, was insufﬁcient when applied to decays obtained from
cells expressing both eGFP-NGT and its mRFP-tagged putative
interacting partners. In this instance data were tail-ﬁtted to bi-
exponential decay model: I(t) = A1exp(t/s1) + A2exp(t/s2), where
s stands for ﬂuorescence lifetime and A for amplitude of individual
contribution. The applied model allows resolving both ﬂuorescence
lifetime and fractional contribution of interacting and non-
interacting donor molecules. Fitting to a single-exponential decay
model besides its invalidity may also lead to underestimation of
FRET efﬁciency as in such case it is assumed that all donors interact
with one or more acceptor(s). To calculate an average lifetime
and fractional amplitudes, respective formulae were used: sav =
(A1s1) + (A2s2)/A1 + A2 and Ai = Ai/Ai + Ai+1.
3. Results and discussion
3.1. Coimmunoprecipitation demonstrates complex formation
between NGT and UGT
Several reports demonstrated that NSTs function in the form of
homodimers [21–23] or higher homooligomers [24], and UGT
forms heterologous complexes with ceramide galactosyltransfer-
ase [25]. Recently we showed that UGT splice variants undergo
partial relocalization when coexpressed, suggesting their mutual
interaction [16]. Moreover, we demonstrated that overexpression
of NGT may partially restore galactosylation of N-glycans in
MDCK-RCAr and CHO-Lec8 mutant cells defective in UGT activity
[17]. Residual galactosylation detected in the mutant cells
[11,26–28], at least in part, suggests that other NSTs may support
this process in the absence of UGT. Taking into account similarity
of NGT and UGT (Supplementary Fig. 1) [2,17–19] we assumed that
these two NSTs may form heterologous complexes in the Golgi
membrane.
To conﬁrm our hypothesis, we ﬁrst employed coimmunoprecip-
itation analysis. Putative complex formation was studied in UGT-
deﬁcient mutant MDCK-RCAr cells, which theoretically should
cause all NGT molecules to interact with recombinant UGTs
exclusively. After overexpression of both UGT splice variants in
MDCK-RCAr cells a complex formation was observed (Fig. 1C),
demonstrating optimal conditions of cell lysis and coimmunopre-
cipitation. Further we demonstrated that NGT and UGT2 as well
as NGT and UGT1 formed complexes (Fig. 1A and B). These
in vitro results for the ﬁrst time revealed an interaction occurring
between two different NSTs. However, coimmunoprecipitation
performed on multitransmembrane proteins in the presence of
detergents may result in non-speciﬁc, false positive results.
Fig. 1. Coimmunoprecipitation analysis of complexes formed between UDP-N-acetylglucosamine transporter (NGT) and UDP-galactose transporter (UGT). Combinations of
(A and B) NGT-HA and both splicing variants of UGT (UGT1-c-myc and UGT2-c-myc), (C) UGT1-HA and UGT2-FLAG, (D) NGT-HA and B4-FLAG (UDP-xylose/N-
acetylglucosamine transporter) or NGT-HA and UGT2-FLAG were overexpressed in MDCK-RCAr mutant cells. Cell lysate proteins were subjected to coimmunoprecipitation
using anti-HA antibody and Protein A-Sepharose 4B. Complexes formed were visualized using Western blotting with anti-c-myc (A and B) or anti-FLAG (C and D) antibodies
and chemiluminescence staining (top panels). Protein staining with colloidal Coomassie Brilliant Blue (bottom panels) served as a control of lysis efﬁciency and protein
loading for coimmunoprecipitation. Arrowheads indicate coimmunoprecipitated complexes.
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negative control. As shown in Fig. 1D we did not observe any
interaction between NGT and UDP-xylose/N-acetylglucosamine
multitransmembrane transporter SLC35B4 (Fig. 1D).
3.2. FLIM–FRET analysis conﬁrms complex formation between NGT
and UGT
To investigate protein–protein interactions in cells a variety of
microscopic techniques has been developed. Our previous studies
demonstrated that after overexpression in MDCK-RCAr cells
UGT1 colocalized with Golgi marker and UGT2 with ER marker
[16]. However, when UGT1 and UGT2 were overexpressed in par-
allel, UGT1 colocalized with both ER and Golgi markers. This sug-
gests that subcellular localization of UGTs may depend not only
on the presence of respective glycosyltransferase [25], but also
on the presence of the partner splice variant. However, such stud-
ies do not provide direct proof of interaction between proteins due
to the insufﬁcient resolving power of the ﬂuorescent microscope.
The most powerful means to demonstrate interaction of proteins
in living cells is based on Förster resonance energy transfer (FRET),
which provides direct information that appropriately labeled do-
nor and acceptor molecules are positioned in the nanometer-range
proximity [29]. The efﬁciency of energy transfer between an ex-
cited donor and a nearby acceptor may be used as a molecular ruler
to determine the distance spacing proteins. One possible methodto quantify FRET efﬁciency is based on measurement and compar-
ison of donor ﬂuorescence lifetime in the presence and absence of
acceptor by using ﬂuorescence lifetime imaging microscopy (FLIM)
[29]. Shortening of the donor ﬂuorescence lifetime indicates FRET,
however, consideration of protein–protein interaction requires fur-
ther analysis to identify the source of lifetime reduction. One can
assume that in detection volume either a fraction of donor coupled
with acceptor or all labeled molecules are interacting. The advan-
tage of FRET measurement by FLIM is the possibility to resolve be-
tween these two elements accounting for the overall efﬁciency of
energy transfer. Performing analysis of FLIM–FRET data using mul-
ti-exponential decay models reveals both fractional contribution
and ﬂuorescence lifetimes of interacting and non-interacting spe-
cies. Therefore, to conﬁrm interaction between NGT and UGT
in vivo, we employed a combined FLIM–FRET approach.
NSTs are exceptionally suitable FRET partners due to their rela-
tively small size and convenient topology (both N and C termini are
directed to the cytosolic side of the membrane and therefore can
be easily tagged). FRET is more efﬁcient when the acceptor is the
protein of higher stoichiometry, which minimizes the percentage
of unpaired donor molecules [30]. Our numerous preliminary
experiments demonstrated that UGT2 and UGT1 are overexpressed
in higher amounts compared with NGT (data not shown). There-
fore, eGFP (a FRET donor) attached to NGT and mRFP (a FRET
acceptor) attached to UGT splice variants were used. Respective
tagged NSTs were overexpressed in MDCK-RCAr cells and
Table 1
In vivo FLIM–FRET analysis of interactions between UDP-N-acetylglucosamine transporter (NGT) and UDP-galactose transporter (UGT).
FRET combinations n sa (ns) ss (ns) fs sl (ns) v2
eGFP-NGT alone 14 2.68 ± 0.02 – 1.00 2.68 ± 0.02 1.00 ± 0.01
eGFP-NGT + mRFP-UGT2 13 2.45 ± 0.04 1.06 ± 0.11 0.18 ± 0.03 2.73 ± 0.1 1.00 ± 0.03
eGFP-NGT + mRFP-UGT1 15 2.53 ± 0.03 1.02 ± 0.18 0.1 ± 0.01 2.69 ± 0.02 1.00 ± 0.05
eGFP-NGT + mRFP-NGT 19 2.53 ± 0.05 0.98 ± 0.12 0.11 ± 0.02 2.73 ± 0.04 0.99 ± 0.03
Abbreviations used: n, number of cells examined; sa, average ﬂuorescence lifetime ± standard deviation (SD); ss, ﬂuorescence lifetime of the interacting donor fraction ± SD; s,
ﬂuorescence lifetime of the non-interacting donor fraction ± SD; fs, the interacting donor fraction ± SD; eGFP, enhanced green ﬂuorescent protein; mRFP, monomeric red
ﬂuorescent protein; NGT, UDP-N-acetylglucosamine transporter; UGT, UDP-galactose transporter.
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time measurements in the absence and presence of the acceptor
(Table 1 and Fig. 2). First we examined subcellular localization of
ﬂuorescently labeled NSTs in living cells. eGFP-NGT (Fig. 2A) and
mRFP-UGT1 (data not shown) localized exclusively to the Golgi
apparatus when expressed alone, while mRFP-UGT2 resided in
the ER only (Fig. 2B). These results are consistent with data ob-
tained using immunoﬂuorescence analysis [16]. Interestingly,
simultaneous overexpression of eGFP-NGT and mRFP-UGT2 re-
sulted in partial relocalization of both recombinant proteins and
a remarkable amount of mRFP-UGT2 could be detected in the Golgi
apparatus (Fig. 2F), where the majority of eGFP-NGT resided
(Fig. 2E). Differences in UGT isoforms are conﬁned to the dilysine
motif present at the C terminus of UGT2, responsible for its ER
localization [31]. It seems, however, that complex formation withFig. 2. In vivo FLIM–FRET analysis of interactions between UDP-N-acetylglucosamine tr
and time-resolved imaging of NGT-eGFP interaction with UGT2-mRFP (middle panel) and
NGT-eGFP only (top panel, except B). Image taken from cells expressing mRFP-UGT2 onl
NGT coexpression. Bar = 10 lm. Arrowheads indicate areas of NGT (E) and UGT2 (F) colo
data representing average donor lifetimes across images. Red-to-blue color changes re
obtained from corresponding FLIM measurements were plotted as frequency distribut
represents ﬂuorescence lifetime range between 2.4 ns (blue) and 3.1 ns (red).NGT directs UGT2 to the Golgi apparatus despite the ER retention
motif present within the C terminus of the latter. As expected,
within other combinations tested (eGFP-NGT + mRFP-UGT1;
Fig. 2I and J, and eGFP-NGT + mRFP-NGT; data not shown) all NSTs
retained their initial Golgi localization.
Subsequent FLIM measurements revealed that in the absence of
an acceptor ﬂuorophore (referred to as control), lifetime of eGFP-
tagged NGT was 2.68 ns (Fig. 2C and D and Table 1). This lifetime
was signiﬁcantly shortened upon coexpression with mRFP-UGT2
(Fig. 2G and H and Table 1), mRFP-UGT1 (Fig. 2K and L and Table
1), and mRFP-NGT (Table 1). A more thorough analysis of FLIM data
acquired for the ﬂuorescently labeled NST combinations (NGT–
NGT, NGT–UGT1, NGT–UGT2) allowed distinguishing two distinct
lifetime components: a longer one (2.7 ns), corresponding to that
of control and an additional shorter one (1 ns) (Table 1). Weansporter (NGT) and UDP-galactose transporter (UGT). Confocal intensity-resolved
UGT1-mRFP (bottom panel) in MDCK-RCAr cells in comparison with cells expressing
y (B) is presented to emphasize partial relocalization of the transporter upon eGFP-
calization within the Golgi apparatus. (C), (G), (K) show typical pseudocolored FLIM
ﬂect shortening of the ﬂuorescence lifetime. Average ﬂuorescence lifetime values
ion histograms (D), (H), (L). The rainbow scale bar placed above each histogram
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interacting donor fraction, while the shorter one results from the
energy transfer between the donor and acceptor. The lifetime of
the shorter component suggests comparably tight association be-
tween NGT and both UGT splice variants as well as between two
NGT monomers. However, its fractional contribution was relatively
low (0.1–0.18), which may be explained by the reasons mentioned
below. One may assume that NSTs have a tendency to dimerize in
an as yet undetermined orientation. We successfully demonstrated
that similar to UGT1 [20], also NGT oligomerizes in vivo (Table 1).
Therefore, additional interactions are highly possible to occur,
resulting in the formation of one or more of the following
homo- and heterologous complexes: (1) eGFP-NGT/eGFP-NGT;
(2) mRFP-NGT/mRFP-NGT; (3) eGFP-NGT/endogenous NGT; (4)
mRFP-NGT/endogenous NGT; (5) mRFP-UGT/endogenous NGT;
(6) mRFP-UGT/mRFP-UGT. Obviously, none of these interactions
would support FRET, instead reducing amounts of donor and
acceptor molecules available for interactions resulting in energy
transfer. Another possible explanation is based on the assumption
that NGT and UGT are not the sole constituents of discovered
complexes. In such a scenario, the extent of interactions between
overexpressed NSTs would largely depend on the availability of
endogenous complementary proteins. Lastly, a high contribution
of the non-interacting donor fraction might result in some cases
from the incomplete folding of the acceptor ﬂuorophore as well
as from the suboptimal donor orientation towards the acceptor.
Surprisingly, the size of the interacting donor fraction was
signiﬁcantly higher for UGT2-bound acceptor compared with
UGT1 (Table 1). This could be explained by differences in UGTs
overexpression levels [11]. However, one cannot exclude the
possibility of differences resulting from dissimilarities between
C-terminal sequences of UGTs, accounting for slightly altered
afﬁnities towards NGT.4. Conclusions
To date, several NSTs have been characterized; however, their
function is still not clear. Since NGT and UGT are evolutionarily re-
lated, and overexpression of NGT in UGT-defective cells may re-
store galactosylation, we hypothesize that NGT speciﬁcity is
broader than previously believed. We postulate that heterologous
NGT/UGT complexes might mediate transport of both UDP-Gal
and UDP-GlcNAc. Alternatively, NGT/UGT heterodimers could sim-
ply bring NGT and UGT homodimers together (providing that high-
er order oligomers are likely to occur as well). In either case,
however, the ability of NGT and UGT to interact with each other
would comprise one of the mechanisms involved in precise spatio-
temporal regulation of N-glycan biosynthesis in the Golgi appara-
tus by ensuring sufﬁcient amounts of UDP-GlcNAc and UDP-Gal
to respective glycosyltransferases. Taking all together, results
gained in this study add to understanding of glycosylation process,
one of the basic posttranslational modiﬁcations, which affects the
majority of macromolecules.
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